The Food and Drug Administration (FDA) on Thursday gave full approval to Leqembi, the first drug that can change the course of Alzheimer’s disease. The move gives patients a glimmer of hope, and patient advocates and some doctors say it’s the beginning of a new era of Alzheimer’s treatment. But there are lingering questions about […]
